Adam Feuerstein - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Adam Feuerstein's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Adam Feuerstein
Verified
Senior Writer, Biotech, STAT
Boston
Beats
and raising awareness for special needs. political scientificEverything cultural
financial news, commodities
Content
By Allison DeAngelis Verified, Adam Feuerstein Verified, Elaine Chen Verified| STAT Verified Is there more funding coming for the biotech industry? Will the pharmaceutical industry be hit with tariffs? And is it possible to reason with RFK Jr.? We talk about all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. John Crowley, the CEO of industry lobbying group BIO, joins us to discuss the layoffs at the Food and Drug Administration, RFK Jr.’s comments on Novavax’s Covid-19 vaccine, and how the trade group is communicating with the Trump administration.
By Adam Feuerstein Verified| STAT Verified This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. “Always you, with the bad news.” — King Henry VIII to Thomas Cromwell. Biotech stocks and the broader markets snapped higher Wednesday after President Trump announced a 90-day pause on reciprocal tariffs for all countries except China, backing down from a trade policy that had triggered a global macroeconomic crisis.
By Allison DeAngelis Verified, Adam Feuerstein Verified, Elaine Chen Verified| STAT Verified Is there more funding coming for the biotech industry? Will the pharmaceutical industry be hit with tariffs? And is it possible to reason with RFK Jr.? We talk about all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. John Crowley, the CEO of industry lobbying group BIO, joins us to discuss the layoffs at the Food and Drug Administration, RFK Jr.’s comments on Novavax’s Covid-19 vaccine, and how the trade group is communicating with the Trump administration.
Company Info
STAT
STAT News is a digital media outlet focused on health, medicine, and science journalism. Launched in 2015, it specializes in investigative reporting and analysis of medical advancements, pharmaceutical developments, and public health issues. The platform gained significant recognition during the COVID-19 pandemic for its comprehensive coverage, which helped expand its audience and revenue. The company provides in-depth news reporting, features, and opinion pieces from industry experts. It also hosts industry events and collaborates with healthcare organizations through brand partnerships. STAT News operates on a subscription model, offering premium content while temporarily removing paywalls for COVID-19 coverage to enhance public access. With an estimated annual revenue of $56.4 million, the company has seen substantial growth, particularly during the pandemic, and currently employs 364 people.
Boston, Massachusetts, United States
+1 617-929-2260
Founded: 2015